OP-1 LONG-TERM EFFICACY AND SAFETY OF OPEN-LABEL SELADELPAR TREATMENT IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS: INTERIM 2-YEAR RESULTS FROM THE ASSURE STUDY

Authors: Palak J. Trivedi, Cynthia Levy, Kris V. Kowdley, Stuart C. Gordon, Christopher L. Bowlus, Maria Carlota Londoño Hurtado, Gideon M. Hirschfield, Aliya F. Gulamhusien, Eric J. Lawitz, Alejandra Villamil, Alma Ladron de Guevara Cetina, Marlyn J. Mayo, Ziad H. Younes, Oren Shibolet, Kidist K. Yimam, Daniel S. Pratt, Jeong Heo, Ulrike Morgera, Pietro Andreone, Andreas E. Kremer, Christophe Corpechot, Aparna Goel, Adam Peyton, Hany Elbeshbeshy, Daria B. Crittenden, Carrie Heusner, Sarah Proehl, Shuqiong Zhou, Charles A. McWherter

Source: Annals of Hepatology, Vol 29, Iss , Pp 101599- (2024)

Subject Terms: Specialties of internal medicine, RC581-951

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S166526812400382X; https://doaj.org/toc/1665-2681

Access URL: https://doaj.org/article/626163d451204fb3b08b87ac61157f74